Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.

EqualOcean Releases 2026 Chinese GoGlobal HealthTech Brands Top 10 at GGF2026

SHANGHAI, June 11, 2026 — EqualOcean officially released its 2026 Chinese GoGlobal HealthTech Brands Top 10 during the GoGlobal Forum of 100 2026 (GGF2026), one of China’s leading annual forums dedicated to globalization and international business expansion.

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.